Division of Colorectal surgery

Tung-Cheng Chang
- rousse11tmu.edutw
- Division of Colorectal surgery - Associate Professor
- Taipei Medical University Shuang Ho Hospital - Visiting Staff
Person: Researcher
20092025
Yan-Jiun Huang
- d622101001tmu.edutw
- Division of Colorectal surgery - Associate Professor
- Taipei Medical University Hospital - Visiting Staff
- TMU Research Center of Cancer Translational Medicine - Member
Person: Researcher
20082025
Li-Jen Kuo
- kuolijengmailcom
- Division of Colorectal surgery - Associate Professor
- Taipei Medical University Hospital - Visiting Staff
Person: Researcher
20032025

5 Active
6 Finished

Exploring Sh3rf3 as a Biomarker and Target for Overcoming Cetuximab Resistance and Preventing Kras Mutations in Colorectal Cancer
Chang, T.-C. (PI)
8/1/25 → 7/31/26
Project: A - Government Institution › b - National Science and Technology Council
A Translational Investigation to Decipher and Target Stromagenic Switch to Overcome Immune Checkpoint Inhibitor Resistance in Microsatellite Stable Cms4 Colorectal Cancer
Huang, Y.-J. (PI)
8/1/25 → 7/31/26
Project: A - Government Institution › b - National Science and Technology Council
Investigating the Role of Slc35d1 in Colorectal Cancer Progression and Chemoresistance
Wei, P.-L. (PI)
8/1/25 → 7/31/26
Project: A - Government Institution › b - National Science and Technology Council

1931 Citations
23 h-index
104 Article
9 Review article
6 Comment/debate
2 Letter

A Predictive Model for Anastomotic Complications After Sphincter-Preserving Surgery for Rectal Cancer: Integrating Clinical and Anatomical Risk Factors
Kuo, C. Y., Lee, C. Y., Kung, C. H., Ngu, J. C. Y. & Kuo, L. J., 2025, In: Diseases of the Colon and Rectum. 10.1097/DCR.0000000000003938.
Research output: Contribution to journal › Article › peer-review
Aspirin after completion of standard adjuvant therapy for colorectal cancer (ASCOLT): an international, multicentre, phase 3, randomised, double-blind, placebo-controlled trial
Chia, J. W. K., Segelov, E., Deng, Y., Ho, G. F., Wang, W., Han, S., Sharma, A., Ding, K., Chen, G., Jeffery, M. G., Tham, C. K., Ahn, J. B., Nott, L., Zielinski, R., Chao, T.-Y., van Hagen, T., Wei, P.-L., Day, F., Mehta, S. & Yau, T. & 10 others, Peng, J., Hayes, T. M., Li, Y., Gandhi, M., Foo, E. M. J., Rahman, N., Rothwell, P., Ali, R., Simes, J. & Toh, H. C., Mar 2025, In: The Lancet Gastroenterology and Hepatology. 10, 3, p. 198-209 12 p.
Research output: Contribution to journal › Article › peer-review
8 Citations (Scopus)
Clinical impact of pharmacogenetic risk variants in a large chinese cohort
Wei, C. Y., Wen, M. S., Cheng, C. K., Sheen, Y. J., Yao, T. C., Lee, S. L., Wu, J. Y., Tsai, M. F., Li, L. H., Chen, C. H., Fann, C. S. J., Yang, H. C., Huang, Y. T., Chen, H. H., Liu, Y. M., Yeh, E. C., Peng, Y. C., Wang, S. J., Chen, S. P. & Tsai, M. T. & 104 others, Huo, T. I., Su, C. W., Tarng, D. C., Huang, C. C., Fuh, J. L., Lan, K. H., Liu, Y. T., Lu, C. L., Lee, Y. C., Huang, Y. H., Li, C. P., Wang, Y. F., Hsieh, Y. C., Chen, Y. M., Hsiao, T. H., Lin, C. H., Chen, Y. J., Chen, I. C., Mao, C. L., Chang, S. J., Chang, Y. L., Liao, Y. J., Lai, C. H., Lee, W. J., Tung, H., Yen, T. T., Yen, H. C., Chang, J. H., Huang, C. Y., Chan, L., Lin, Y. W., Hsiao, B. Y., Hu, C. J., Lin, Y. K., Lin, Y. F., Chang, T. C., Wu, D. C., Kan, J. Y., Hsu, C. Y., Chen, S. C., Li, C. C., Huang, C. F., Sheu, C. C., Yang, L. J., Chen, C. H., Chen, K. M., Chang, S. M., Liou, M. S., Wang, S. P., Lin, K. T., Chuang, H. P., Chen, Y. J., Sin, J., Chen, Y. T., Chang, C. C., Kuo, C. F., Lin, J. C., Kuo, H. C., Chan, T. M., Lee, C. W., Lai, J. H., Luo, S. F., Cheng, H. T., Lin, L. Y., Chang, L. C., Tsai, C. T., Kao, H. L., Yu, J. J., Jeng, J. S., Chiu, M. C., Hong, T. C., Yang, S. F., Lu, H. J., Su, S. C., Chu, P., Li, P. F., Tsai, C. L., Tsai, C. K., Tang, S. E., Lin, C. M., Wu, Y. F., Huang, C. Y., Ling, S. Z., Chang, C. C., Lin, T. K., Hsiao, S. M., Chang, C. H., Chen, C. D., Ma, G. C., Chang, T. Y., Hwang, J. J., Lu, C. L., Kao, K. J., Hung, C. F., Chen, S. S., Chen, P. Y., Tsui, K., Chen, Y. T., Chen, C. H., Chien, C. C., Chiang, H. S., Chiu, Y. L., Chen, H. C. & Kwok, P. Y., Dec 2025, In: Nature Communications. 16, 1, 6344.
Research output: Contribution to journal › Article › peer-review
3 Citations (Scopus)

Additional file 1: of Maintenance tegafur-uracil versus observation following an adjuvant oxaliplatin-based regimen in patients with stage III colon cancer after radical resection: study protocol for a randomized controlled trial
Tsai, H.-L. (Contributor), Sung, Y.-C. (Contributor), Tang, H.-C. (Contributor), Yeh, Y.-S. (Contributor), Wei, P.-L. (Contributor), Wang, J.-Y. (Contributor) & Huang, C.-W. (Creator), Figshare, 2017
DOI: 10.6084/m9.figshare.c.3751544_d1.v1, https://doi.org/10.6084%2Fm9.figshare.c.3751544_d1.v1
Dataset
Additional file 2: Figure S1. of Ovatodiolide suppresses colon tumorigenesis and prevents polarization of M2 tumor-associated macrophages through YAP oncogenic pathways
Huynh, T.-T. (Contributor), Tzeng, Y.-M. (Contributor), Yen, Y. (Creator), Yang, C.-K. (Contributor), Wu, A. T. (Creator), Meng, T.-C. (Contributor), Whang-Peng, J. (Creator), Wei, P.-L. (Contributor), Hsiao, M. (Creator) & Huang, Y.-J. (Contributor), Figshare, 2017
DOI: 10.6084/m9.figshare.c.3704533_d1.v1, https://doi.org/10.6084%2Fm9.figshare.c.3704533_d1.v1
Dataset
Ovatodiolide suppresses colon tumorigenesis and prevents polarization of M2 tumor-associated macrophages through YAP oncogenic pathways
Huang, Y.-J. (Contributor), Yang, C.-K. (Contributor), Wei, P.-L. (Contributor), Huynh, T.-T. (Contributor), Whang-Peng, J. (Creator), Meng, T.-C. (Contributor), Hsiao, M. (Creator), Tzeng, Y.-M. (Contributor), Wu, A. T. (Creator) & Yen, Y. (Creator), Figshare, 2017
DOI: 10.6084/m9.figshare.c.3704533.v1, https://doi.org/10.6084%2Fm9.figshare.c.3704533.v1
Dataset

Division of Colorectal surgery

Fingerprint

Collaborations and top research areas from the last five years

Dive into details

Tung-Cheng Chang

Yan-Jiun Huang

Li-Jen Kuo

Exploring Sh3rf3 as a Biomarker and Target for Overcoming Cetuximab Resistance and Preventing Kras Mutations in Colorectal Cancer

A Translational Investigation to Decipher and Target Stromagenic Switch to Overcome Immune Checkpoint Inhibitor Resistance in Microsatellite Stable Cms4 Colorectal Cancer

Investigating the Role of Slc35d1 in Colorectal Cancer Progression and Chemoresistance

A Predictive Model for Anastomotic Complications After Sphincter-Preserving Surgery for Rectal Cancer: Integrating Clinical and Anatomical Risk Factors

Aspirin after completion of standard adjuvant therapy for colorectal cancer (ASCOLT): an international, multicentre, phase 3, randomised, double-blind, placebo-controlled trial

Clinical impact of pharmacogenetic risk variants in a large chinese cohort

Additional file 1: of Maintenance tegafur-uracil versus observation following an adjuvant oxaliplatin-based regimen in patients with stage III colon cancer after radical resection: study protocol for a randomized controlled trial

Additional file 2: Figure S1. of Ovatodiolide suppresses colon tumorigenesis and prevents polarization of M2 tumor-associated macrophages through YAP oncogenic pathways

Ovatodiolide suppresses colon tumorigenesis and prevents polarization of M2 tumor-associated macrophages through YAP oncogenic pathways

Division of Colorectal surgery

Fingerprint

Collaborations and top research areas from the last five years

Profiles

Projects

Research output

Datasets